Literature DB >> 18823273

Epidemiology of vancomycin-resistant enterococci among patients on an adult stem cell transplant unit: observations from an active surveillance program.

Michael S Calderwood1, Andreas Mauer, Jocelyn Tolentino, Ernesto Flores, Koen van Besien, Ken Pursell, Stephen G Weber.   

Abstract

OBJECTIVE: To use the findings of an active surveillance program to delineate the unique epidemiology of vancomycin-resistant enterococci (VRE) in a mixed population of transplant and nontransplant patients hospitalized on a single patient care unit.
DESIGN: Surveillance survey and case-control analysis.
SETTING: A 19-bed adult bone marrow and stem cell transplant unit at a referral and primary-care center. PATIENTS: The study included patients undergoing transplantation, patients who had previously received bone marrow or stem cell transplants, and patients with other malignancies and hematological disorders who were admitted to the study unit.
METHODS: Patients not previously identified as colonized with VRE had perirectal swab specimens collected at admission and once weekly while hospitalized on the unit. The prevalence of VRE colonization at admission and the incidence throughout the hospital stay, genotypes of VRE specimens as determined by pulsed field gel electrophoresis, and risk factors related to colonization were analyzed.
RESULTS: There was no significant difference in the prevalence or incidence of new colonization between nontransplant patients and prior or current transplant recipients, although overall prevalence at admission was significantly higher in the prior transplant group. Preliminary genotypic analysis of VRE isolates from transplant patients suggests that a proportion of cases of newly detected VRE carriage may represent prior colonization not detected at admission, with different risk factors suggestive of a potential epidemiological distinction.
CONCLUSION: Examination of epidemiological and microbiological data collected by an active surveillance program provides useful information about the epidemiology of VRE that can be applied to inform rational infection control strategies.

Entities:  

Mesh:

Year:  2008        PMID: 18823273     DOI: 10.1086/591454

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  6 in total

Review 1.  The prevention and management of infections due to multidrug resistant organisms in haematology patients.

Authors:  Jason A Trubiano; Leon J Worth; Karin A Thursky; Monica A Slavin
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335

2.  Efficacy of infection control interventions in reducing the spread of multidrug-resistant organisms in the hospital setting.

Authors:  Erika M C D'Agata; Mary Ann Horn; Shigui Ruan; Glenn F Webb; Joanna R Wares
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

3.  Chlorhexidine bathing for the prevention of colonization and infection with multidrug-resistant microorganisms in a hematopoietic stem cell transplantation unit over a 9-year period: Impact on chlorhexidine susceptibility.

Authors:  Elisa Teixeira Mendes; Otavio T Ranzani; Ana Paula Marchi; Mariama Tomaz da Silva; José Ulysses Amigo Filho; Tânia Alves; Thais Guimarães; Anna S Levin; Silvia Figueiredo Costa
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

Review 4.  Burden and Management of Multidrug-Resistant Organisms in Palliative Care.

Authors:  Rupak Datta; Manisha Juthani-Mehta
Journal:  Palliat Care       Date:  2017-12-19

5.  Colonization With Vancomycin-Resistant Enterococci and Risk for Bloodstream Infection Among Patients With Malignancy: A Systematic Review and Meta-Analysis.

Authors:  Michail Alevizakos; Apostolos Gaitanidis; Dimitrios Nasioudis; Katerina Tori; Myrto Eleni Flokas; Eleftherios Mylonakis
Journal:  Open Forum Infect Dis       Date:  2016-12-07       Impact factor: 3.835

6.  Incidence of and risk factors for infection or colonization of vancomycin-resistant enterococci in patients in the intensive care unit.

Authors:  Sung-Ching Pan; Jann-Tay Wang; Yee-Chun Chen; Yin-Yin Chang; Mei-Ling Chen; Shan-Chwen Chang
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.